Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Board votes to open rulemaking on pharmacy quality‑assurance rules after sharp debate over error reporting
Summary
The California State Board of Pharmacy voted April 30 to begin formal rulemaking to amend CCR §17.11 on quality‑assurance programs after members and public commenters debated whether the board should receive individual or only aggregate medication‑error reports and how automated drug delivery systems should be treated.
The California State Board of Pharmacy voted April 30 to initiate formal rulemaking to amend California Code of Regulations, title 16, section 17.11, the board said, advancing a package that would clarify quality‑assurance program requirements for pharmacies across the state.
Board chair Maria Serpa presented committee‑recommended language to require pharmacies to define quality‑assurance policies that include both individual and aggregate medication‑error analysis. Members spent extensive time debating whether facilities operating under common ownership should be allowed to meet the rule’s requirements through joint, aggregated reviews rather than individual pharmacy reports.
Several members said documentation and communication processes should…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
